In triple-negative breast cancer, GRP78 interacts with PD-L1 in the ER region and increases PD-L1 levels by regulating its stability [20], but there is no research regarding GRP78/PD-L1 in LSCC. Here, HSPA5 is linked to triple-negative breast carcinoma.